2018 annual financial data

UroGen Pharma 2018 Financial results

Direct answer

Revenue was 1,128,000 USD.

Operating income was -77,180,000 USD and net income was -75,657,000 USD.
Operating cash flow was -37,334,000 USD.

Get free UroGen Pharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,128,000 USD
Operating income
-77,180,000 USD
Net income
-75,657,000 USD
Operating cash flow
-37,334,000 USD